Cargando…
Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review
Ulcerative colitis is the chronic relapsing multifactorial gastrointestinal inflammatory bowel disease, which is characterized by bloody or mucus diarrhea, tenesmus, bowel dystension, anemia. The annual incidence of ulcerative colitis in Asia, North America and Europe was found to be 6.3, 19.2 and 2...
Autores principales: | Nidhi, Rashid, Muzamil, Kaur, Veerpal, Hallan, Supandeep Singh, Sharma, Saurabh, Mishra, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908146/ https://www.ncbi.nlm.nih.gov/pubmed/27330377 http://dx.doi.org/10.1016/j.jsps.2014.10.001 |
Ejemplares similares
-
Ellagic Acid Containing Nanostructured Lipid Carriers for Topical Application: A Preliminary Study
por: Singh Hallan, Supandeep, et al.
Publicado: (2020) -
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis
por: Li, Meng, et al.
Publicado: (2022) -
Challenges in the Physical Characterization of Lipid Nanoparticles
por: Hallan, Supandeep Singh, et al.
Publicado: (2021) -
Lipid-Based Nano-Sized Cargos as a Promising Strategy in Bone Complications: A Review
por: Hallan, Supandeep Singh, et al.
Publicado: (2022) -
Oral Delivery of Pterostilbene by L-Arginine-Mediated “Nano-Bomb” Carrier for the Treatment of Ulcerative Colitis
por: Wei, Wei, et al.
Publicado: (2022)